All News

Jeff Hunnicutt, CEO of Highlands Oncology Group, discusses the difference between business intelligence and artificial intelligence (AI), including process implementation and data compilation.

Surgeon General warns of social media’s harm; additional women in Texas cite health risks from abortion bans; White House supports bill against fentanyl trafficking.

On this episode of Managed Care Cast, we feature several leaders in diversity, equity, and inclusion advancing health equity in their respective organization’s policy and practice initiatives.

Posters presented at the 2023 American Thoracic Society International Conference called for improvements in care for chronic obstructive pulmonary disease (COPD) and pulmonary hypertension.

Gerard Criner, MD, FACP, FACCP, professor and founding chair, Thoracic Medicine and Surgery, at the Lewis Katz School of Medicine at Temple University, discusses a new trial that investigated how long treatment would last for patients with emphysema, and if any complications arose.

The majority of respondents living with generalized myasthenia gravis (MG) were not working, the results showed.

Debra Boyer, MD, pediatric pulmonologist at Nationwide Children’s Hospital and co-chair of the American Thoracic Society (ATS) International Conference Committee, says that more needs be done for children who have respiratory diseases to improve their adult health outcomes.

At the Pharmacy Quality Alliance (PQA) 2023 Annual Meeting, the strategy advancement lead at Humana talked more about Humana’s health equity strategy and areas that pharmacy benefit managers (PBMs) and health plans can influence.

Mitzi Joi Williams, MD, FAAN, medical director and CEO, Joi Life Wellness Neurology Clinic, addresses several reasons that have potential to delay a correct multiple sclerosis (MS) diagnosis in minority patient populations, including social determinants of health.

Two studies, one of zanubrutinib alone and one that combined the therapy with tislelizumab, showed promising results in a subset of patients.

Coverage from the Greater Philadelphia Business Coalition on Health (GPBCH) daylong Oncology Management Summit, held April 4, 2023.

The World Health Organization (WHO) prepares for the next pandemic; new restrictions on reproductive health services in the South; Thermo Fisher Scientific receives FDA approval for a first-of-its-kind preeclampsia test.

Coverage from the Greater Philadelphia Business Coalition on Health (GPBCH) daylong Oncology Management Summit, held April 4, 2023.

Quantifying social determinants of health and addressing the factors that allow disparities to persist will require standardized measurements and targeted interventions, said a panel of experts at the 2023 American Thoracic Society International Conference.

Researchers took both the learning curve of the new process and the COVID-19 pandemic into consideration.

Nicholas Bagley, JD, professor at Michigan Law at the University of Michigan, discusses how Congress can help address the consequences of Braidwood v Becerra.

Rupal Shah, MD, associate professor at the University of California San Francisco, talks about how the onset of the COVID-19 pandemic created an opportunity for patients who have undergone a lung transplant to undergo spirometry testing at home instead of at the the hospital.

Mark A. Socinski, MD, executive director of the AdventHealth Cancer Institute, shared his thoughts on the most important recent advances in non–small cell lung cancer (NSCLC), including a better understanding of patients who may benefit from immunotherapy.

In the phase 3 BOREAS study of patients with chronic obstructive pulmonary disease (COPD) and type 2 inflammation, patients treated with dupilumab experienced fewer COPD exacerbations, improved lung function, and improved quality of life compared with patients given a placebo.

Although the condition is rare and cases are limited, researchers were able to generally conclude vagal nerve stimulation (VNS) serves as a well-tolerated intervention.

Upgrading a building's ventilation system can improve the delivery of clean air while maintaining energy efficiency and low costs, according to the CDC.

After 1 year, overall treatment switch rates were 14.4%, while after 2 years, switch rates were 26%.

Telehealth provides more flexibility for patients with gastrointestinal issues to better fit their care into their lives and around symptoms they may be experiencing, said Sam Holliday, co-founder and CEO of Oshi Health.

Investigators said disease-modifying therapies may change the treatment landscape of sickle cell disease (SCD).

Neil Goldfarb, president and chief executive officer of the Greater Philadelphia Business Coalition on Health (GPBCH), gives a preview of what attendees can expect at the 2023 GPBCH Annual Conference.

Amneal Pharmaceuticals this week launched its pegfilgrastim biosimilar, Fylnetra (pegfilgrastim-pbbk), for the treatment and prevention of febrile neutropenia, making it the sixth biosimilar referencing Neulasta to enter the US market.

Having at least 2 episodes of severe hypoglycemia that required hospitalization was found to be a major predictor for time to death in individuals with type 1 diabetes (T1D).

Despite the use of nocturnal noninvasive ventilation (NIV), patients report having poor quality of sleep, according to a recent study.

In the phase 3 SINUS-24 and SINUS-52 trials, dupilumab improved clinical outcomes and and health-related quality of life among patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and clinical features of obstructive lung disease.

Between 2010 and 2020, pediatric antiretroviral therapy (ART) coverage tripled, but still consistently lagged behind adult ART coverage.